Den Haag: The European Union’s drug regulator said on Thursday in a discussion with Astrazeneca on the possibility of the authorization of the booster dose of the covid-19 vaccine drug, after that it had given a green light to the MRNA Booster Shots.
“Astrazeneca sent data to us.
Actually today they send new data packages that can support extensions to use booster,” the head of the European drug vaccine strategy, Marco Cavaleri, told the briefing.
“We will discuss with them whether this data is enough for (authorization) or whether we need more evidence,” Cavalry added.
EMA had previously provided a vaccine in the future by vaccines by Pfizer-Bionalech Alliance and by Modera, both based on RNA Messenger technology, to be given as a third booster dose of at least six months after standard two-shot courses.
The focus of the booster campaign in Europe was initially in the elderly and on those who had a weakened immune system but the larger part of the population was called to seek third shots.